Found 5 matching trials
Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells
PHASE1In the laboratory, we will put a special gene into cancer cells that have b...
Location
Multiple Locations
Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells
PHASE1This is a research study to determine the safety and dosage of special cell...
Location
The Methodist Hospital
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
PHASE1This is a research study to determine the safety and effectiveness of using...
Location
Houston Methodist Hospital
Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
PHASE1We would like patients to be in a research study to determine the safety an...
Location
The Methodist Hospital
Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells
PHASE1This study is for patients that have chronic lymphocytic leukemia (CLL). Th...
Location
The Methodist Hospital